Tracking migraine outcomes over time by age and monoclonal antibody type: a retrospective, single-center, real-world study.

Aimovig (erenumab-aooe) - Amgen

Vyepti (eptinezumab-jjmr) - Teva, Lundbeck

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Ajovy (fremanezumab-vfrm) - Teva

http://www.ncbi.nlm.nih.gov/pubmed/42662958

Alessandro Padovani; Alessandro Rondina; Alice Lanfranchi; Andrea Pilotto; Elena Cresta; Giulia Ceccardi; Irene Mattioli; Michele Di Pasquale; Renata Rao

Aug 29, 2026